TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7622989

Group type: EXPERIMENTAL
Intervention: Elicited imitation with verbal elaboration opportunity
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nonverbal measures
Number of subjects: 12
Study: 2497130

Group type: EXPERIMENTAL
Intervention: Progesterone (10 mg, im)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: RU 486 (10 or 100 mg, orally)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 16
Study: 19188

Group type: EXPERIMENTAL
Intervention: Clorazepate dipotassium (15 mg) with antacid suspension
Number of subjects: 15

Group type: COMPARATOR
Intervention: Clorazepate dipotassium (15 mg) alone
Number of subjects: 15
Study: 7246998

Group type: EXPERIMENTAL
Intervention: Brevimytal (premedicated group)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Trapanal (premedicated group)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Halothane (inhalational agent)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Enflurane (inhalational agent)
Number of subjects: 139

Group type: COMPARATOR
Intervention: No premedication (Trapanal or Brevimytal)
Number of subjects: 139
Study: 31800053

Group type: EXPERIMENTAL
Intervention: Higher nicotine option (cigarettes ≥ 5.3 mg/g)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Nicotine nasal spray (2.5 µg/kg)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Very low or no nicotine option (cigarettes ≤ 2.3 mg/g and placebo spray)
Number of subjects: 101
Study: 29513683

Group type: EXPERIMENTAL
Intervention: mHealth app (DiaSocial)
Number of subjects: 27
Study: 26874820

Group type: EXPERIMENTAL
Intervention: Fractional carbon-dioxide laser-assisted topical therapy with terbinafine cream (once-daily for 3 months)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Fractional carbon-dioxide laser-assisted topical therapy
Number of subjects: 75
Study: 24954487

Group type: EXPERIMENTAL
Intervention: Non‐tourniquet group
Number of subjects: 70

Group type: COMPARATOR
Intervention: Tourniquet group
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 22424623

Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 209
Study: 19091806

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 81

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 81
Study: 17991660

Group type: EXPERIMENTAL
Intervention: White wine (20 g ethanol/d for 4 weeks)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Red wine (20 g ethanol/d for 4 weeks)
Number of subjects: 35
Study: 16192580

Group type: COMPARATOR
Intervention: Cisplatin 80 mg/m2 IV on day 1 alone (arm A)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Cisplatin 80 mg/m2 IV on day 1 combined with raltitrexed 3 mg/m2 (arm B)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Cisplatin alone (arm A)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Cisplatin combined with raltitrexed (arm B)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Cisplatin with raltitrexed (arm B)
Number of subjects: 250
Study: 11960042

Group type: EXPERIMENTAL
Intervention: GnRH analog and iron plus tibolone (group A)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Only iron (group C)
Number of subjects: 66
Study: 9821415

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide 800 micrograms once daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Inhaled budesonide 400 micrograms twice daily
Number of subjects: 24
Study: 7666812

Group type: EXPERIMENTAL
Intervention: 21-day regimen of estradiol valerate (EV) opposed with cyproterone acetate (CPA)
Number of subjects: 38

Group type: COMPARATOR
Intervention: 28-day regimen of conjugated equine estrogens (CEE) with norgestrel (NG)
Number of subjects: 38
Study: 2680179

Group type: EXPERIMENTAL
Intervention: Topical 2% minoxidil
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 340306

Group type: EXPERIMENTAL
Intervention: Clomipramine (50 mg twice daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31308630

Group type: EXPERIMENTAL
Intervention: Tablet form of mycophenolate mofetil (500 mg)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Capsule form of mycophenolate mofetil (250 mg)
Number of subjects: 116
Study: 29131002

Group type: EXPERIMENTAL
Intervention: Low tidal volume (VT) of 6 mL/kg and moderate positive end-expiratory pressure (PEEP) of 8 cm H2O
Number of subjects: 44

Group type: COMPARATOR
Intervention: High tidal volume (VT) of 10 mL/kg and zero end-expiratory pressure (ZEEP)
Number of subjects: 44
Study: 26081329

Group type: EXPERIMENTAL
Intervention: Mexidol (500 mg/day intravenously for 14 days, then 500 mg twice a day orally for 60 days)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no mexidol)
Number of subjects: 45
Study: 23652373

Group type: EXPERIMENTAL
Intervention: 30 minutes of moderate‐to‐vigorous aerobic exercise five times a week for approximately 16 weeks
Number of subjects: 391

Group type: COMPARATOR
Intervention: Usual‐lifestyle sedentary control group
Number of subjects: 391
Study: 21131165

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (PEI)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 140
Study: 19708896

Group type: EXPERIMENTAL
Intervention: Hygiene promotion intervention based on germ awareness
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control arm (no intervention)
Number of subjects: 300
Study: 17361495

Group type: EXPERIMENTAL
Intervention: hydroxyzine 25 mg/d
Number of subjects: 50

Group type: COMPARATOR
Intervention: doxepin 10 mg/d
Number of subjects: 50
Study: 15281538

Group type: COMPARATOR
Intervention: loss‐of‐resistance with air
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: loss‐of‐resistance with lidocaine
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: loss‐of‐resistance with both air and lidocaine
Number of subjects: 547
Study: 10828232

Group type: EXPERIMENTAL
Intervention: Duplex scanning
Number of subjects: 69
Study: 9110743

Group type: EXPERIMENTAL
Intervention: Seven therapeutic nursing interventions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Decisional control (control group)
Number of subjects: 50
Study: 7903008

Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (hCG)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone (GnRH)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study: 2938615

Group type: EXPERIMENTAL
Intervention: Topical azelaic acid
Number of subjects: 45

Group type: COMPARATOR
Intervention: Oral tetracycline
Number of subjects: 45
Study: 31144674

Group type: EXPERIMENTAL
Intervention: Combination of rivaroxaban 2.5 mg twice daily and aspirin 100 mg once daily
Number of subjects: 27395

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 27395
Study: 28678944

Group type: EXPERIMENTAL
Intervention: CPP-ACP chewing gum
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Conventional sugar free chewing gum
Number of subjects: 8

Group type: COMPARATOR
Intervention: No chewing gum (control)
Number of subjects: 8
Study: 25997770

Group type: EXPERIMENTAL
Intervention: Intervention designed to prevent risk‐taking behaviors
Number of subjects: 172

Group type: COMPARATOR
Intervention: Services as usual (SAU)
Number of subjects: 172
Study: 23762355

Group type: EXPERIMENTAL
Intervention: Cupping massage
Number of subjects: 61

Group type: COMPARATOR
Intervention: Progressive muscle relaxation
Number of subjects: 61
Study: 20886278

Group type: EXPERIMENTAL
Intervention: Audio computer‐assisted self‐interviewing (ACASI)
Number of subjects: 849

Group type: COMPARATOR
Intervention: Face‐to‐face interview (FTFI)
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: ACASI
Number of subjects: 849

Group type: COMPARATOR
Intervention: FTFI
Number of subjects: 849
Study: 18647810

Group type: EXPERIMENTAL
Intervention: 10 mg daily im P administration
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 40 mg daily im P administration
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (natural cycles)
Number of subjects: 29
Study: 16244481

Group type: EXPERIMENTAL
Intervention: Olanzapine (average dose 4.71 mg)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Haloperidol (average dose 1.75 mg)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Olanzapine and Haloperidol
Number of subjects: 58
Study: 12917230

Group type: EXPERIMENTAL
Intervention: 400 mg moxifloxacin
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 300 mg isoniazid
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 600 mg rifampin
Number of subjects: 3
Study: 10535609

Group type: EXPERIMENTAL
Intervention: HAART plus IL-2
Number of subjects: 21

Group type: COMPARATOR
Intervention: HAART alone
Number of subjects: 21
Study: 8557903

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 19394

Group type: COMPARATOR
Intervention: Open control (no lisinopril)
Number of subjects: 19394

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate
Number of subjects: 19394

Group type: COMPARATOR
Intervention: Open control (no glyceryl trinitrate)
Number of subjects: 19394
Study: 1801054

Group type: EXPERIMENTAL
Intervention: norfloxacin 200 mg at night
Number of subjects: 88

Group type: COMPARATOR
Intervention: macrocrystalline nitrofurantoin 100 mg at night
Number of subjects: 88
Study: 6225686

Group type: EXPERIMENTAL
Intervention: sorbinil
Number of subjects: 15
Study: 31609296

Group type: EXPERIMENTAL
Intervention: High salt intake (3900 mg·d)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham trial (60 min of seated rest)
Number of subjects: 19
Study: 30707881

Group type: EXPERIMENTAL
Intervention: Active abdominal compression‐decompression cardiopulmonary resuscitation (AACD‐CPR), n = 24
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cardiopulmonary resuscitation (CPR) with unarmed abdominal compression, n = 21
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: AACD‐CPR
Number of subjects: 45
Study: 28968543

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 2275
Study: 27083930

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (LCZ696) 400 mg
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (LCZ696) 1200 mg
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg (positive control)
Number of subjects: 84
Study: 25122979

Group type: EXPERIMENTAL
Intervention: Oscillating-rotating toothbrush (Oral-B Triumph with SmartGuide and FlossAction brush head)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Sonic toothbrush (Sonicare FlexCare Platinum)
Number of subjects: 130
Study: 21916999

Group type: EXPERIMENTAL
Intervention: TCH (1.35% taurolidine, 4% citrate and 500 U/ml heparin)
Number of subjects: 106

Group type: COMPARATOR
Intervention: TC (1.35% taurolidine in 4% citrate)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Heparin 5000 U/ml
Number of subjects: 106
Study: 20465525

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 1139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1139

Group type: COMPARATOR
Intervention: Routine-care
Number of subjects: 1139
Study: 17345042

Group type: EXPERIMENTAL
Intervention: Memantine (10 mg, bi.d.)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Memantine (once-daily dosing)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Memantine (once-daily dosing during titration and short-term maintenance therapy)
Number of subjects: 314
Study: 16280695

Group type: EXPERIMENTAL
Intervention: Enfuvirtide
Number of subjects: 997

Group type: COMPARATOR
Intervention: Optimized background regimen alone (Control)
Number of subjects: 997
Study: 12032018

Group type: COMPARATOR
Intervention: Saline (3 mL)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Lidocaine (30 mg)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Tramadol (50 mg)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Fentanyl (100 microg)
Number of subjects: 250
Study: 9477390

Group type: COMPARATOR
Intervention: Low carotenoid diet with 0.5 mg/day of Beta-carotene (Group C)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Low carotenoid diet without supplementation (Group P)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both groups received 0.5 mg/day of Beta-carotene (Group C and Group P) during period 2
Number of subjects: 9
Study: 7879830

Group type: EXPERIMENTAL
Intervention: Redox tolerance test before percutaneous transhepatic biliary drainage
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Redox tolerance test after percutaneous transhepatic biliary drainage
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Redox tolerance test before drainage with RTI < 0.5
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Hospital mortality in patients with initial RTI < 0.5
Number of subjects: 29
Study: 1994656

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 2377
Study: 6558739

Group type: EXPERIMENTAL
Intervention: Developmental method of counseling
Number of subjects: 122

Group type: COMPARATOR
Intervention: Conventional method of counseling
Number of subjects: 122

Group type: COMPARATOR
Intervention: Negative pregnancy test counseling
Number of subjects: 122

Group type: COMPARATOR
Intervention: Routine medical visit counseling
Number of subjects: 122
Study: 29707867

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser therapy followed by narrow band ultraviolet‐B (NB‐UVB) phototherapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Narrow band ultraviolet‐B (NB‐UVB) alone
Number of subjects: 32
Study: 30275526

Group type: EXPERIMENTAL
Intervention: Azacitidine 75 mg/m2/day x7 days
Number of subjects: 485

Group type: COMPARATOR
Intervention: Conventional care regimens (CCR)
Number of subjects: 485
Study: 26502869

Group type: EXPERIMENTAL
Intervention: Oral UDCA 4×250 mg daily (Group 1)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intravenous SAMe 1000 mg daily (Group 2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of UDCA and SAMe (Group 3)
Number of subjects: 120
Study: 24060628

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy focused on eating disorder features
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy focused on mood intolerance, clinical perfectionism, core low self-esteem or interpersonal difficulties
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both programmes
Number of subjects: 80
Study: 21883279

Group type: EXPERIMENTAL
Intervention: Five-grass-pollen daily tablet sublingually for 4 months
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 19958547

Group type: EXPERIMENTAL
Intervention: Preventive home visits (PHV) intervention, 4 times over a 12 month follow-up period.
Number of subjects: 110

Group type: COMPARATOR
Intervention: Minimal intervention of mailed printed materials (comparison group).
Number of subjects: 110
Study: 16487162

Group type: EXPERIMENTAL
Intervention: Paired associative stimulation (PAS) between a TMS pulse and an electrical stimulus to the median nerve
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Motor practice of rapid thumb abduction
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sensory input produced by semicontinuous muscle vibration
Number of subjects: 6
Study: 15489468

Group type: EXPERIMENTAL
Intervention: Physical activity (measured by CSA activity monitors)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Mean METS per minute
Number of subjects: 210
Study: 10758689

Group type: EXPERIMENTAL
Intervention: Amalgam
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: EBA
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 79
Study: 8828025

Group type: EXPERIMENTAL
Intervention: Ebastine 10 mg/day for 2 weeks
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Ebastine 10 mg/day for 4 months
Number of subjects: 116

Group type: COMPARATOR
Intervention: Astemizole 10 mg/day for 4 months
Number of subjects: 116
Study: 1593044

Group type: EXPERIMENTAL
Intervention: Palmaz‐Schatz stent
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Directional atherectomy
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Laser balloon angioplasty
Number of subjects: 223

Group type: COMPARATOR
Intervention: All interventions
Number of subjects: 223
Study: 6741445

Group type: EXPERIMENTAL
Intervention: 30 ml Gelusil orally (Group I, n = 17)
Number of subjects: 33

Group type: COMPARATOR
Intervention: 30 ml of 0.3 mol/l sodium citrate (Group II, n = 16)
Number of subjects: 33
Study: 31350167

Group type: EXPERIMENTAL
Intervention: Symptomatic CVT patients
Number of subjects: 812
Study: 29396246

Group type: EXPERIMENTAL
Intervention: Methylprednisolone plus mycophenolate
Number of subjects: 164

Group type: COMPARATOR
Intervention: Methylprednisolone alone
Number of subjects: 164
Study: 25647351

Group type: EXPERIMENTAL
Intervention: PM cues with category discrepancy (Body Parts)
Number of subjects: 0

Group type: COMPARATOR
Intervention: PM cues with category congruence
Number of subjects: 0
Study: 24617270

Group type: EXPERIMENTAL
Intervention: Thoughts of gratitude intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acts of kindness intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 22398106

Group type: EXPERIMENTAL
Intervention: Physical activity intervention (up to three face-to-face and ten telephone contacts over 8 months)
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 361

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 361
Study: 20517084

Group type: EXPERIMENTAL
Intervention: Fibrin glue and quilting
Number of subjects: 35

Group type: COMPARATOR
Intervention: Quilting alone
Number of subjects: 35
Study: 18024309

Group type: EXPERIMENTAL
Intervention: Vitamin B6 and folic acid treatment in addition to aspirin and IVIG
Number of subjects: 76

Group type: COMPARATOR
Intervention: Aspirin and IVIG alone
Number of subjects: 76
Study: 15655011

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) 1500 mg and Methylene Blue (MB) 780 mg over 3 days
Number of subjects: 74
Study: 11863236

Group type: EXPERIMENTAL
Intervention: Parental information group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Contact-control condition
Number of subjects: 60
Study: 10448728

Group type: EXPERIMENTAL
Intervention: No implant
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Lyophilized dura implant
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ethisorb implant
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: e-PTFE implant
Number of subjects: 70

Group type: COMPARATOR
Intervention: Implants (combined)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Overall (no implant vs implants)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Wound complications
Number of subjects: 70
Study: 8574160

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) during consolidation chemotherapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo during consolidation chemotherapy
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) during induction chemotherapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo during induction chemotherapy
Number of subjects: 56
Study: 2086411

Group type: EXPERIMENTAL
Intervention: CAB contact lenses
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: HEMA contact lenses
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no contact lenses)
Number of subjects: 50
Study: 264991

Group type: EXPERIMENTAL
Intervention: Branch A of the randomised DAL study series (1/71)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Intensified initial therapy (11/73)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Cytosin-arabinoside orally
Number of subjects: 78
Study: 31364911

Group type: EXPERIMENTAL
Intervention: Wixela Inhub (100/50 μg FP/S)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Wixela Inhub (250/50 μg FP/S)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Wixela Inhub (500/50 μg FP/S)
Number of subjects: 66
Study: 30674347

Group type: EXPERIMENTAL
Intervention: Community Paramedicine at Home (CP@home) program intervention
Number of subjects: 261

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 261
Study: 28695641

Group type: EXPERIMENTAL
Intervention: Nerve-sparing radical hysterectomy (NSRH)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Conventional radical hysterectomy (CRH)
Number of subjects: 87
Study: 24888575

Group type: EXPERIMENTAL
Intervention: ADIM (free-mixed aspart and detemir insulin)
Number of subjects: 82

Group type: COMPARATOR
Intervention: ANIM (premixed fixed-ratio aspart and NPH insulin)
Number of subjects: 82
Study: 23624756

Group type: COMPARATOR
Intervention: ZT-1 (0.5 mg, po)
Number of subjects: 58

Group type: COMPARATOR
Intervention: ZT-1 (0.75 mg, po)
Number of subjects: 58

Group type: COMPARATOR
Intervention: ZT-1 (0.75 mg/d, po) for 8 consecutive days
Number of subjects: 58

Group type: COMPARATOR
Intervention: ZT-1 (0.5, 0.75, 1, 1.25 or 1.5 mg, po)
Number of subjects: 58
Study: 21306949

Group type: EXPERIMENTAL
Intervention: Positional therapy with therapeutic pillow
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control night with hospital pillow and ad lib positioning
Number of subjects: 18
Study: 19207633

Group type: EXPERIMENTAL
Intervention: CAPSLE (a systems and mentalization focused whole school intervention)
Number of subjects: 1345

Group type: EXPERIMENTAL
Intervention: CAPSLE
Number of subjects: 1345

Group type: COMPARATOR
Intervention: SPC (School Psychiatric Consultation)
Number of subjects: 1345

Group type: COMPARATOR
Intervention: TAU (treatment‐as‐usual)
Number of subjects: 1345
Study: 16477425

Group type: EXPERIMENTAL
Intervention: 12/14F coaxial ureteral dilator/sheath and a 7.5F flexible ureteroscope (group A; 48 patients)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Balloon dilatation and the 7.5F flexible ureteroscope (group B; 50 patients)
Number of subjects: 98
Study: 14760324

Group type: EXPERIMENTAL
Intervention: abciximab infusion for 24 hours
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: abciximab infusion for 48 hours
Number of subjects: 404

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 404